Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
48.64
-1.01 (-2.03%)
At close: Mar 20, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.